FTO and ovarian carcinoma: Using bioinformatics analyses of transcriptomic data derived from ovarian cancer patients and normal controls in publicly available databases such as TCGA and GEO,20, 21, 22 we identified FTO as a significantly DEG in ovarian cancer.